Hori M, Oniki K, Ueda K, Goto S, Mihara S, Marubayashi T, Nakagawa K.
Combined glutathione-S-transferase T1 and M1 positive genotypes afford protection against type 2 diabetes in Japanese.
Pharmacogenomics 8, 1307-1314, 2007.

Seo T, Pahwa P, McDuffie HH, Shindo J, Goto S, Hashimoto M, Sunita G, Nakagawa K.
Influence of paraoxonase-1 Q192R polymorphism on the lung function in Saskatchewan grain handlers.
Pharmacogenomics 8, 901-908, 2007.

Ueda K, Ishitsu T, Seo T, Ueda N, Murata T, Hori M, Nakagawa K.
Combined glutathione-S-transferase M1 and T1 null genotypes as a risk factor for carbamazepine-induced mild hepatotoxicity.
Pharmacogenomics 8, 435-442, 2007.

Oniki K, Ueda K, Hori M, Mihara S, Marubayashi T, Nakagawa K.
Combined glutathione-S-transferase M1 and T1 null genotypes as a risk factor for alcoholic mild liver dysfunction.
Clin Pharm Ther 81, 634-635, 2007.

Nakao M, Muramoto Y, Hisadome M, Yamano N, Shoji M, Fukushima Y, Saruwatari J, Nakagawa K.
The effect of Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s, N-acetyltransferase 2 and xanthine oxidase in extensive or intermediate metabolizers of CYP2D6.
Eur J Clin Pharmacol 63, 345-353, 2007.

Goto S, Seo T, Murata T, Nakada N, Ueda N, Ishitsu T, Nakagawa K.
Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese.
Ther Drug Monit 29, 118-121, 2007.

Shuto K, Furuta T, Cheung J, Gruenert DC, Ohira Y, Shimasaki S, Suico MA,
Sato K, Kai H.
Increased responsiveness to TLR2 and TLR4 ligands during dimethylsulfoxide-induced neutrophil-like differentiation of HL-60 myeloid leukemia cells.
Leuk Res 31, 1721-1728, 2007.